| NAUT Stock | | | USD 2.24 0.06 2.61% |
Nautilus Biotechnology financial indicator trend analysis is infinitely more than just investigating Nautilus Biotechnology recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Nautilus Biotechnology is a good investment. Please check the relationship between Nautilus Biotechnology Capital Stock and its Accounts Payable accounts. Check out
Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nautilus Biotechnology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in employment.
For more information on how to buy Nautilus Stock please use our
How to Invest in Nautilus Biotechnology guide.
Capital Stock vs Accounts Payable
Capital Stock vs Accounts Payable Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
Nautilus Biotechnology Capital Stock account and
Accounts Payable. At this time, the significance of the direction appears to have almost identical trend.
The correlation between Nautilus Biotechnology's Capital Stock and Accounts Payable is 0.98. Overlapping area represents the amount of variation of Capital Stock that can explain the historical movement of Accounts Payable in the same time period over historical financial statements of Nautilus Biotechnology, assuming nothing else is changed. The correlation between historical values of Nautilus Biotechnology's Capital Stock and Accounts Payable is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Capital Stock of Nautilus Biotechnology are associated (or correlated) with its Accounts Payable. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Accounts Payable has no effect on the direction of Capital Stock i.e., Nautilus Biotechnology's Capital Stock and Accounts Payable go up and down completely randomly.
Correlation Coefficient | 0.98 |
| Relationship Direction | Positive |
| Relationship Strength | Very Strong |
Capital Stock
The total amount of a company's capital funded by shareholders through the issue and subscription of shares.
Accounts Payable
An accounting item on the balance sheet that represents Nautilus Biotechnology obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Nautilus Biotechnology are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.
Most indicators from Nautilus Biotechnology's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Nautilus Biotechnology current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nautilus Biotechnology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in employment.
For more information on how to buy Nautilus Stock please use our
How to Invest in Nautilus Biotechnology guide.
Selling General Administrative is likely to drop to about 25.5
M in 2024.
Enterprise Value Over EBITDA is likely to drop to -5.49 in 2024
Nautilus Biotechnology fundamental ratios Correlations
Click cells to compare fundamentals
Nautilus Biotechnology Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Nautilus Biotechnology fundamental ratios Accounts
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Additional Tools for Nautilus Stock Analysis
When running Nautilus Biotechnology's price analysis, check to
measure Nautilus Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nautilus Biotechnology is operating at the current time. Most of Nautilus Biotechnology's value examination focuses on studying past and present price action to
predict the probability of Nautilus Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nautilus Biotechnology's price. Additionally, you may evaluate how the addition of Nautilus Biotechnology to your portfolios can decrease your overall portfolio volatility.